Delivery Order SPE2DB22D2007-SPE2DB24FJ1MA
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,260,909 tablets of 500 mg Clarithromycin. The $13,134.91 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The delivery order was issued under an indefinite delivery contract (IDC) held by...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,525.20, is for the delivery of Clarithromycin 500 mg tablets. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,499.27 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Clarithromycin 125 mg/5 ml suspension in 100 ml bottles. This contract has a completion date of January 18, 2023 and is structured as a Firm Fixed Price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Clarithromycin 500 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 3, 2025, carries a ceiling value of $1,219.55 and is set to be completed by September 4, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.83 Firm Fixed Price Delivery Order contract is for the provision of 60-count bottles of Clarithromycin 500 mg tablets. The contract has a period of performance through May 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,272,269 tablets of Clarithromycin 500 mg to the U.S. Department of Defense (DoD). The contract, a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,035.37 and a completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,378.42 firm-fixed-price delivery order is for the supply of Clarithromycin 250 mg tablets. The contract has an ultimate completion date of December 7, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Clarithromycin 500 mg tablets. The contract has a ceiling value of $1,196.60 and a completion date of July 17, 2025. The award is not set-aside and was competitively granted. AmerisourceBergen Drug Corp, a for-profit organization, is a critical vendor for federal medical procurement, particularly supporting military and...
- This federal contract award is for the delivery of 4,560,070,715 tablets of Clarithromycin 500 mg to the Defense Logistics Agency (DLA). The contract, valued at $1,157.91, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Clarithromycin 250 mg tablets. The contract has a ceiling value of $1,366.18 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 25, 2024. This contract award is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ1MADelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of Clarithromycin 500 mg tablets in quantities of 60 per bottle. The award, valued at $1,037.72, has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not designated as a set-aside contract.
Generated 7/12/24, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/12/24 |